Position in BLTE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,256,865
New position
Shares Held
7,883
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Voleon Capital Management LP holds $189,781,068 across 60 Biotechnology names. BLTE ranks #26 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
147,867 | $24,992,480 | |
| 2 | SRPT |
Sarepta Therapeutics, Inc.
|
800,660 | $17,422,361 | |
| 3 | ASND |
Ascendis Pharma A/S
|
67,839 | $15,516,814 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
150,513 | $13,904,390 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
262,223 | $10,570,209 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
1,157,158 | $8,875,401 | |
| 7 | ABVX |
Abivax S.A.
|
73,726 | $8,209,390 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,074 | $7,965,364 |
All Filings in BLTE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,256,865 | 7,883 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||